First Surgical Implant of ZIP ULTRA(TM) MIS Interspinous Implant Performed in Poland

Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first surgical
implant of its ZIP ULTRA(TM) Minimally Invasive Interspinous Fusion Implant in
Poland. The surgery was performed by Prof, Jacek Kaczmarczyk at the
Ortopedyczno-Rehabilitacyjny Szpital Kliniczny nr 4w Poznaniu, Poznan, Polska.


"We are pleased to begin commercialization of the Aurora ZIP(TM) MIS
Interspinous Fusion System in Poland and would like to thank Viktor DEGI MEDICAL
UNIVERSITY for performing the procedure", said Trent J. Northcutt, President and
CEO of Aurora Spine Corporation. "We passionately believe the ZIP MIS
Interspinous Fusion Systems represents a significant opportunity to provide a
better spinal fusion option for doctors, hospital systems and patients globally.
The success of our screw-less spine procedure is a testament to our laser focus
on disruptive technology and our commitment to - Simplifying the Complex". 


This surgery is part of Aurora's continuing efforts to expand the use of its MIS
device in Europe. Aurora's technology enables surgeons to expand patient
selection, treat a wide range of spinal disorders and drive the shift toward
minimally invasive techniques.


About Aurora Spine 

Aurora Spine is an early stage company focused on bringing new solutions to the
spinal implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.


Forward-Looking Statements 

This news release contains forward-looking information that involves substantial
known and unknown risks and uncertainties, most of which are beyond the control
of Aurora Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking information").
Forward-looking information in this news release includes information concerning
the proposed use and success of Aurora Spine's products in surgical procedures.
Aurora Spine cautions investors of its securities about important factors that
could cause Aurora Spine's actual results to differ materially from those
projected in any forward-looking statements included in this news release. Any
statements that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and may be forward-looking and may involve estimates,
assumptions and uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking statements. No
assurance can be given that the expectations set out herein will prove to be
correct and, accordingly, prospective investors should not place undue reliance
on these forward looking statements. These statements speak only as of the date
of this press release and Aurora Spine does not assume any obligation to update
or revise them to reflect new events or circumstances.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004


Aurora Spine Corporation
Eric Fronk
Chief Financial Officer
(760) 424-2004

Aurora Spine (TSXV:ASG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024